- Technology
- SEE MORE
- classical
- general
- talk
- News
- Family
- Bürgerfunk
- pop
- Islam
- soul
- jazz
- Comedy
- humor
- wissenschaft
- opera
- baroque
- gesellschaft
- theater
- Local
- alternative
- electro
- rock
- rap
- lifestyle
- Music
- como
- RNE
- ballads
- greek
- Buddhism
- deportes
- christian
- piano
- djs
- Dance
- dutch
- flamenco
- social
- hope
- christian rock
- academia
- afrique
- Business
- musique
- ελληνική-μουσική
- religion
- World radio
- Zarzuela
- travel
- World
- NFL
- media
- Art
- public
- Sports
- Gospel
- st.
- baptist
- Leisure
- Kids & Family
- musical
- club
- Culture
- Health & Fitness
- True Crime
- Fiction
- children
- Society & Culture
- TV & Film
- gold
- kunst
- música
- gay
- Natural
- a
- francais
- bach
- economics
- kultur
- evangelical
- tech
- Opinion
- Government
- gaming
- College
- technik
- History
- Jesus
- Health
- movies
- radio
- services
- Church
- podcast
- Education
- international
- Transportation
- Other
- kids
- podcasts
- philadelphia
- Noticias
- love
- sport
- Salud
- film
- and
- 4chan
- Disco
- Stories
- fashion
- Arts
- interviews
- hardstyle
- entertainment
- humour
- medieval
- literature
- alma
- Cultura
- video
- TV
- Science
- en
#42 Injective: Multichain Derivative Markets with Eric Chen
b'
On the show today we have Eric Chen, co-founder and CEO of Injective Protocol. Injective is an EVM-compatible, interoperable order-book based decentralised exchange that acts as a layer-2 sidechain, built using Tendermint-based consensus. Injective\\u2019s canary-chain phase 2 mainnet recently went live earlier in July, which introduced staking and governance to the network. Injective\\u2019s Governance has already passed the activation of spot market trading and is likely to enable derivative trading soon. We caught up with Eric to discuss Injective\\u2019s go-to-market strategy, the mechanism for proposing arbitrary markets using governance, how Injective improves price discovery for liquid staking assets, their unique usage of yield boosting for community participation, institutional interest in Injective and much more.
'